SCHEMBL17425530

SCHEMBL17425530

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc(-c4cccc5c4oc4c(-c6ccccc6)cccc45)c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.43
ALDH1A1 P00352 5/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
KDM4E B2RXH2 3/20 0.43
TSHR P16473 3/20 0.43
TP53 P04637 2/20 0.43
NFKB1 P19838 2/20 0.43
HSD17B10 Q99714 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPT P10636 2/20 0.43
HPGD P15428 2/20 0.43
MAPK1 P28482 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43
ATM Q13315 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
PRKDC P78527 8/20 0.43
PIK3CD O00329 3/20 0.42
PIK3CA P42336 3/20 0.42
PIK3CB P42338 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21425303 1.00 ALOX5 (0.43) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL17425512 0.98 PRKDC (0.42) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL16441577 0.98 ALOX5 (0.42) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL18216737 0.98 ALOX5 (0.42) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL16441608 0.98 ALOX5 (0.46) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL16441447 0.98 ALOX5 (0.44) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL24703262 0.97 ALOX5 (0.44) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL17425619 0.97 ALOX5 (0.44) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL22925273 0.97 PRKDC (0.44) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR
SCHEMBL17425672 0.97 ALOX5 (0.44) ALOX5ALDH1A1SMN1; SMN2KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022124827-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 솔루스첨단소재 주식회사 2022-06-16 WO disclosed
US-20170054087-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-02-23 US disclosed
US-20160093808-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-03-31 US disclosed
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2016-01-28 US disclosed
EP-2966706-A2 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2016-01-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160028021-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, OR10J3 ALOX5 336/4885ALDH1A1 1130/4885SMN1; SMN2 2722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.